Predictive value of ELR combined with CT scores for olfactory recovery in CRSwNP.

IF 4.7 2区 医学 Q1 ALLERGY
Liufeiyan Fan, Zhong Zheng, Haofei Bai, Silyu Jing, Chunyang Zhang, Weijia Du, Yubin Lai, Min Xu, Jian Wang, Tao Xue, Fuquan Chen
{"title":"Predictive value of ELR combined with CT scores for olfactory recovery in CRSwNP.","authors":"Liufeiyan Fan, Zhong Zheng, Haofei Bai, Silyu Jing, Chunyang Zhang, Weijia Du, Yubin Lai, Min Xu, Jian Wang, Tao Xue, Fuquan Chen","doi":"10.1016/j.anai.2025.10.009","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Chronic rhinosinusitis with nasal polyps (CRSwNP) is a debilitating inflammatory disease often complicated by olfactory dysfunction (OD). Despite surgery being a primary treatment, predicting postoperative olfactory recovery remains challenging. Eosinophilic inflammation and sinus computed tomography (CT) characteristics may serve as prognostic markers, yet their combined utility in predicting OD outcomes is underexplored.</p><p><strong>Objective: </strong>To investigate the predictive effect of eosinophil-to-lymphocyte ratio (ELR) from peripheral blood tests, combined with ethmoid sinus-to-maxillary sinus (E/M) ratio, and ethmoid sinus score minus maxillary sinus (E-M) score on olfactory recovery in CRSwNP patients.</p><p><strong>Methods: </strong>This single-center, retrospective cohort study was conducted from January 2022 to June 2024. A total of 137 CRSwNP patients and 52 healthy controls were included. Preoperative and postoperative olfactory functions were assessed using the Sniffin' Sticks test. ELR, E/M ratio, and E-M score were calculated based on blood tests and CT scans. Logistic regression analysis and receiver operating characteristic (ROC) curve analysis were used to identify and validate predictive factors for olfactory recovery.</p><p><strong>Results: </strong>The median preoperative TDI score was 10 (IQR 7-24), improving to 26 (IQR 15-33) at 6 months postoperatively, with a median improvement (ΔTDI) of 7 (IQR 2-14). ELR, E/M ratio, and E-M score were significantly higher in patients with poor olfactory recovery (all p < 0.05). Logistic regression analysis showed that ELR (Model 1: OR = 1.199; Model 2: OR = 1.209), E/M ratio (OR = 3.236), and E-M score (OR = 2.179) were independent risk factors for poor olfactory prognosis. ROC curve analysis showed that the Combined Index showed superior predictive performance.</p><p><strong>Conclusion: </strong>A composite model integrating ELR with CT-based E/M ratio or E-M score effectively predicts olfactory recovery in CRSwNP patients. These accessible biomarkers aid in stratifying patients for personalized treatment and postoperative monitoring.</p>","PeriodicalId":50773,"journal":{"name":"Annals of Allergy Asthma & Immunology","volume":" ","pages":""},"PeriodicalIF":4.7000,"publicationDate":"2025-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Allergy Asthma & Immunology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.anai.2025.10.009","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Chronic rhinosinusitis with nasal polyps (CRSwNP) is a debilitating inflammatory disease often complicated by olfactory dysfunction (OD). Despite surgery being a primary treatment, predicting postoperative olfactory recovery remains challenging. Eosinophilic inflammation and sinus computed tomography (CT) characteristics may serve as prognostic markers, yet their combined utility in predicting OD outcomes is underexplored.

Objective: To investigate the predictive effect of eosinophil-to-lymphocyte ratio (ELR) from peripheral blood tests, combined with ethmoid sinus-to-maxillary sinus (E/M) ratio, and ethmoid sinus score minus maxillary sinus (E-M) score on olfactory recovery in CRSwNP patients.

Methods: This single-center, retrospective cohort study was conducted from January 2022 to June 2024. A total of 137 CRSwNP patients and 52 healthy controls were included. Preoperative and postoperative olfactory functions were assessed using the Sniffin' Sticks test. ELR, E/M ratio, and E-M score were calculated based on blood tests and CT scans. Logistic regression analysis and receiver operating characteristic (ROC) curve analysis were used to identify and validate predictive factors for olfactory recovery.

Results: The median preoperative TDI score was 10 (IQR 7-24), improving to 26 (IQR 15-33) at 6 months postoperatively, with a median improvement (ΔTDI) of 7 (IQR 2-14). ELR, E/M ratio, and E-M score were significantly higher in patients with poor olfactory recovery (all p < 0.05). Logistic regression analysis showed that ELR (Model 1: OR = 1.199; Model 2: OR = 1.209), E/M ratio (OR = 3.236), and E-M score (OR = 2.179) were independent risk factors for poor olfactory prognosis. ROC curve analysis showed that the Combined Index showed superior predictive performance.

Conclusion: A composite model integrating ELR with CT-based E/M ratio or E-M score effectively predicts olfactory recovery in CRSwNP patients. These accessible biomarkers aid in stratifying patients for personalized treatment and postoperative monitoring.

ELR结合CT评分对CRSwNP嗅觉恢复的预测价值。
背景:慢性鼻窦炎伴鼻息肉(CRSwNP)是一种衰弱性炎症性疾病,常并发嗅觉功能障碍(OD)。尽管手术是主要的治疗方法,但预测术后嗅觉恢复仍然具有挑战性。嗜酸性粒细胞炎症和鼻窦计算机断层扫描(CT)特征可以作为预后标志物,但它们在预测OD结果方面的综合效用尚未得到充分探讨。目的:探讨外周血嗜酸性粒细胞与淋巴细胞比值(ELR)、筛窦与上颌窦比值(E/M)、筛窦评分减去上颌窦评分对CRSwNP患者嗅觉恢复的预测作用。方法:这项单中心、回顾性队列研究于2022年1月至2024年6月进行。共纳入137例CRSwNP患者和52例健康对照。术前和术后使用嗅探棒试验评估嗅觉功能。根据血液检查和CT扫描计算ELR、E/M比和E-M评分。采用Logistic回归分析和受试者工作特征(ROC)曲线分析确定并验证嗅觉恢复的预测因素。结果:术前TDI评分中位数为10分(IQR 7-24),术后6个月改善至26分(IQR 15-33),中位数改善(ΔTDI)为7分(IQR 2-14)。嗅觉恢复较差患者的ELR、E/M比、E-M评分均显著高于对照组(p < 0.05)。Logistic回归分析显示,ELR(模型1:OR = 1.199;模型2:OR = 1.209)、E/M比(OR = 3.236)、E-M评分(OR = 2.179)是嗅觉预后不良的独立危险因素。ROC曲线分析表明,综合指数具有较好的预测效果。结论:将ELR与基于ct的E/M比值或E-M评分相结合的复合模型可有效预测CRSwNP患者的嗅觉恢复情况。这些可获得的生物标志物有助于对患者进行分层,以便进行个性化治疗和术后监测。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.50
自引率
6.80%
发文量
437
审稿时长
33 days
期刊介绍: Annals of Allergy, Asthma & Immunology is a scholarly medical journal published monthly by the American College of Allergy, Asthma & Immunology. The purpose of Annals is to serve as an objective evidence-based forum for the allergy/immunology specialist to keep up to date on current clinical science (both research and practice-based) in the fields of allergy, asthma, and immunology. The emphasis of the journal will be to provide clinical and research information that is readily applicable to both the clinician and the researcher. Each issue of the Annals shall also provide opportunities to participate in accredited continuing medical education activities to enhance overall clinical proficiency.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信